Group 1: BYD Company Limited (1211 HK) - The company reported revenue of CNY 237.7 billion and net profit of CNY 9.29 billion for Q4 2025, with a gross margin under pressure at 17.4% due to industry competition, but strict cost control ensured a solid profit base [1] - Future growth is expected to be driven by the new generation of hybrid technology and ramping up production capacity overseas in Southeast Asia, Latin America, and Europe, enhancing profit margins [1] - The target price has been raised to HKD 138.53, reflecting a potential upside of 30.9%, with EPS forecasts for 2026-27 increased by 7.1% and 8.8% respectively [1] Group 2: China National Heavy Duty Truck Group (3808 HK) - The company achieved revenue of CNY 58.7 billion in the second half of 2025, a year-on-year increase of 27%, and net profit of CNY 3.59 billion, up 40% year-on-year, with a significant reduction in expense ratio to 8.4% [3] - Geopolitical uncertainties have increased demand for land transportation in the Middle East, coupled with the cost-performance advantage of domestic heavy trucks, serving as core growth catalysts [3] - The target price has been raised to HKD 45.80, maintaining a buy rating, with expectations for profits to reach CNY 8.6 billion in 2026 [3] Group 3: Weichai Power Co., Ltd. (2338 HK) - The company faced short-term pressure on earnings due to main business concessions and impairments, but the underlying profit structure has significantly improved [4] - High-margin large bore engines and a surge in sales of AIDC-compatible power sources have demonstrated strong pricing power, with North American orders extending to 2028 [4] - The target price has been adjusted to HKD 31.30, maintaining a buy rating as the company transitions from a traditional commercial vehicle cycle stock to a global core supplier of power sources [4] Group 4: EVE Energy Co., Ltd. (300014 CH) - The company reported a revenue of CNY 61.47 billion for 2025, a year-on-year increase of 26.4%, with a net profit of CNY 4.13 billion, up 1.4% year-on-year [6] - The fourth quarter saw improved profitability due to increased capacity utilization and price increases for certain energy storage products, with gross and net profit margins at 16.8% and 8.0% respectively [6] - The target price remains at CNY 94.74, with a buy rating, as the company accelerates overseas capacity expansion [6] Group 5: Great Wall Motors (2333 HK) - The company achieved revenue of CNY 222.82 billion in 2025, a year-on-year increase of 10.2%, but net profit fell to CNY 9.87 billion, down 22.1% year-on-year due to increased marketing expenses [7] - The launch of the AI "Guiyuan" platform and ramping up production at the Brazil factory are expected to drive performance recovery in 2026 [7] - The target price has been lowered to HKD 17.50, maintaining a buy rating due to the company's strong pricing power in the off-road segment [7] Group 6: Rongchang Biopharmaceutical (9995 HK) - The company is expected to achieve breakeven in 2026, with product sales revenue for 2025 projected to increase by 35.8% to CNY 2.307 billion [8] - The sales of key products like Taitasip and Vidisizumab are expected to contribute significantly to revenue growth, with management forecasting over 25% growth in 2026 [8] - The target price is set at HKD 136.00, maintaining a buy rating as the company rapidly iterates its technology pipeline [8] Group 7: Innovent Biologics (1801 HK) - The company reported a 45% year-on-year increase in product revenue to CNY 11.9 billion for 2025, with the addition of seven innovative drug products [10] - The sales of the drug Ma Shidu Peptide are expected to reach CNY 1.8 billion in 2026, becoming a key growth driver [10] - The target price is set at HKD 105.00, maintaining a buy rating as the company expands its commercial product portfolio [10]